OTC · Medical - Care Facilities

Jinxin Fertility Group Limited (JXFGF) Stock

$0.29 +0.00% OTC: JXFGF Healthcare

Jinxin Fertility Group Limited, established in 2003 and headquartered in Chengdu, China, functions as an investment holding company primarily focused on delivering assisted reproductive services (ARS) across both China and the United States. The company offers a comprehensive range of fertility treatments, encompassing artificial insemination, which can be performed using either a husband's or donor sperm, and advanced in vitro fertilization (IVF) techniques such as conventional IVF with embryo transfer or IVF enhanced by intracytoplasmic sperm injection (ICSI).

Valuation

MetricValue
Price$0.29
Market Cap$740.34M
P/E Ratio-5.35
P/B Ratio0.41
P/S Ratio1.94
EPS (TTM)$-0.35
52-Week High$0.50
52-Week Low$0.20
Dividend Yield3.45%

Financials & Margins

MetricValue
ROE-10.66%
ROA-7.00%
ROCE0.82%
Gross Margin32.57%
Operating Margin3.89%
Net Margin-37.21%
Debt/Equity0.32
Current Ratio0.87

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.8B$2.4B$2.8B$2.8B$2.6B
Operating Profit$371.0M$285.0M$480.0M$454.0M$198.0M
Net Profit$340.0M$121.0M$345.0M$283.0M$-951.0M
EPS$0.14$0.05$0.12$0.10$-0.35
Op Margin20.2%12.1%17.2%16.1%7.7%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$12.8B$15.2B$14.9B$15.0B$14.0B
Total Liabilities$4.1B$6.5B$4.7B$4.6B$4.8B
Cash$862.0M$1.3B$624.0M$546.0M$906.0M
Borrowings$2.1B$4.2B$2.5B$2.6B$3.0B

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$343.0M$542.0M$684.0M$629.0M$476.0M
Investing Cash Flow$-1.6B$-2.3B$-549.0M$-556.0M$-413.0M
Financing Cash Flow$-102.0M$-819.0M$-275.0M$-295.0M$-200.0M
Net Cash Flow$-275.0M$-359.0M$-639.0M$-121.0M$383.0M
Free Cash Flow$264.0M$-418.0M$511.0M$367.0M$218.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.01
EV / EBITDA17.55
FCF Yield5.19%
Quick Ratio0.83
Interest Coverage1.53
Return 1Y21.01%
Return 3Y-31.26%
Return 5Y—

Ownership

Insiders Held12.90%
Institutions Held15.94%
Institutions Float Held18.30%
Institutional HolderSharesReport Date
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund33,006,0152026-04-30
VANGUARD Intl Eqy. INDEX Fd.S-Vanguard Emerging Markets Stock Index Fd30,794,0002026-04-30
iShares, Inc.-iShares Core MSCI Emerging Markets ETF25,249,5002026-06-30
American Century ETF Trust-Avantis Emerging Markets Equity ETF17,647,5002026-06-30
DFA INVESTMENT DIMENSIONS GROUP INC-Emerging Markets Core Eqy. 2 PORT.14,386,5002026-04-30

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
GGNDFGN Store Nord A/S $13.39 +0.00% -35.71 $1.95B 0.00%
GNNDYGN Store Nord A/S $41.99 -1.40% -35.71 $2.04B 0.00%
HAWPYHaw Par Corporation Limited $53.50 +0.00% 13.52 $2.96B 1.16%
MCRPFMicroPort Scientific Corp. $0.85 +0.00% 35.38 $1.63B 0.00%
MCVEFMedicover AB (publ) $27.25 +0.00% 36.01 $4.14B 0.84%

About Jinxin Fertility Group Limited

Jinxin Fertility Group Limited, established in 2003 and headquartered in Chengdu, China, functions as an investment holding company primarily focused on delivering assisted reproductive services (ARS) across both China and the United States. The company offers a comprehensive range of fertility treatments, encompassing artificial insemination, which can be performed using either a husband's or donor sperm, and advanced in vitro fertilization (IVF) techniques such as conventional IVF with embryo transfer or IVF enhanced by intracytoplasmic sperm injection (ICSI). Supporting these core services, Jinxin also provides patients with nutritional guidance, traditional Chinese medicine therapies, and psychological counseling. Furthermore, its operations extend to general medical services including gynecology, urology, and internal medicine, along with managing outpatient surgical facilities and various ancillary medical provisions. The group also conducts pre-implantation genetic screening tests and engages in diverse ventures like investment management, management consultancy, and real estate development and operation.

Jinxin Fertility Group Limited is headquartered in CN.

Jinxin Fertility Group Limited (JXFGF) stock trades at $0.29 with a market capitalization of $740.34M. The stock is valued at a price-to-earnings (P/E) ratio of -5.35, price-to-book of 0.41, price-to-sales of 1.94. Over the past 52 weeks the stock has ranged between $0.20 and $0.50, and currently trades 42.0% below its 52-week high. It pays a dividend yielding 3.45%.

On profitability, Jinxin Fertility Group Limited generates a return on equity (ROE) of -10.66%, return on capital employed of 0.82%, an operating margin of 3.89%, a net profit margin of -37.21%.

Official website: www.jxr-fertility.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides